Related Experiment Video
Updated: Jul 6, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia
Marcello Romiti1, Maximiano Albers, Francisco Cardoso Brochado-Neto
1Vascular Surgery Section, Department of Surgery, Health and Medical Sciences Sector, Lusiada Foundation, Santos, Sao Paulo, Brazil.
Insights
Crural angioplasty offers acceptable limb salvage for chronic critical limb ischemia, comparable to bypass surgery. However, its technical success and durability are limited, necessitating further research for optimal patient treatment strategies.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Regenerative Medicine
Background:
- Infrainguinal arterial occlusive disease is increasingly treated with percutaneous transluminal angioplasty.
- Crural angioplasty is a key intervention for chronic critical limb ischemia.
- Comparative outcomes with bypass surgery are crucial for treatment decisions.
Purpose of the Study:
- To assess the mid-term outcomes of crural angioplasty in patients with chronic critical limb ischemia.
- To compare crural angioplasty results with a meta-analysis of popliteal-to-distal vein bypass graft outcomes.
Main Methods:
- Meta-analysis of 30 studies published between 1990 and 2006.
- Inclusion of studies with at least 15 infrapopliteal angioplasties and 12-month patency or limb salvage data.
- Analysis of immediate technical success, primary/secondary patency, limb salvage, and patient survival using survival analysis.
Main Results:
- Immediate technical success rate was 89.0%.
- 1-year primary patency was 77.4%, secondary patency 83.3%, limb salvage 93.4%, and patient survival 98.3%.
- Outcomes were poorer for limbs with tissue loss, except for limb salvage and survival.
Conclusions:
- Crural angioplasty has limited technical success and durability compared to bypass surgery.
- Limb salvage rates for crural angioplasty are equivalent to bypass surgery, offering acceptable clinical benefit.
- Further research is needed to define the optimal role of infrapopliteal angioplasty.
Background:
Percutaneous transluminal angioplasty has been used with increasing frequency in the treatment of infrainguinal arterial occlusive disease. This meta-analysis aimed to assess the middle-term outcomes after crural angioplasty in patients with chronic critical limb ischemia and compare results with a meta-analysis of popliteal-to-distal vein bypass graft.
Methods:
Data were retrieved from 30 articles published from 1990 through 2006 (63% of articles published between 2000 and 2006). All studies used survival analysis, reported a 12-month cumulative rate of patency or limb salvage, and included at least 15 infrapopliteal angioplasties. The outcome measures were immediate technical success, primary and secondary patency, limb salvage, and patient survival. Data from life-tables, survival curves, and texts were used.
Results:
The pooled estimate of success was 89.0% +/- 2.2% for immediate technical result. Results at 1 and 36 months were 77.4% +/- 4.1% and 48.6% +/- 8.0% for primary patency, 83.3% +/- 1.4% and 62.9% +/- 11.0% for secondary patency, 93.4% +/- 2.3% and 82.4% +/- 3.4% for limb salvage, and 98.3% +/- 0.7% and 68.4% +/- 5.5% for patient survival, respectively. Studies with >75% of the limbs with tissue loss fared worse than their respective comparative subgroup for technical success and patency but not for limb salvage or survival. No publication bias was detected.
Conclusion:
The technical success and subsequent durability of crural angioplasty are limited compared with bypass surgery, but the clinical benefit is acceptable because limb salvage rates are equivalent to bypass surgery. Further studies are necessary to determine the proper role of infrapopliteal angioplasty.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

